MX2019006992A - Vacunacion eficaz contra cepas europeas del virus del sindrome reproductivo y respiratorio porcino (prrs) previo al destete. - Google Patents
Vacunacion eficaz contra cepas europeas del virus del sindrome reproductivo y respiratorio porcino (prrs) previo al destete.Info
- Publication number
- MX2019006992A MX2019006992A MX2019006992A MX2019006992A MX2019006992A MX 2019006992 A MX2019006992 A MX 2019006992A MX 2019006992 A MX2019006992 A MX 2019006992A MX 2019006992 A MX2019006992 A MX 2019006992A MX 2019006992 A MX2019006992 A MX 2019006992A
- Authority
- MX
- Mexico
- Prior art keywords
- weaning
- prrs
- respiratory syndrome
- porcine reproductive
- vaccination against
- Prior art date
Links
- 241000700605 Viruses Species 0.000 title abstract 3
- 208000005342 Porcine Reproductive and Respiratory Syndrome Diseases 0.000 title abstract 2
- 238000002255 vaccination Methods 0.000 title abstract 2
- 241000282898 Sus scrofa Species 0.000 abstract 1
- 230000002238 attenuated effect Effects 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/10011—Arteriviridae
- C12N2770/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/10011—Arteriviridae
- C12N2770/10051—Methods of production or purification of viral material
- C12N2770/10052—Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/10011—Arteriviridae
- C12N2770/10061—Methods of inactivation or attenuation
- C12N2770/10064—Methods of inactivation or attenuation by serial passage
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662434144P | 2016-12-14 | 2016-12-14 | |
| PCT/US2017/066347 WO2018112169A2 (en) | 2016-12-14 | 2017-12-14 | Effective vaccination against european strains of porcine reproductive and respiratory syndrome (prrs) virus prior to weaning |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2019006992A true MX2019006992A (es) | 2019-08-29 |
Family
ID=60957443
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2019006992A MX2019006992A (es) | 2016-12-14 | 2017-12-14 | Vacunacion eficaz contra cepas europeas del virus del sindrome reproductivo y respiratorio porcino (prrs) previo al destete. |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US11090376B2 (https=) |
| EP (1) | EP3554537A2 (https=) |
| JP (1) | JP7129978B2 (https=) |
| KR (2) | KR20190085977A (https=) |
| CN (1) | CN110072547B (https=) |
| AU (1) | AU2017378336B2 (https=) |
| BR (1) | BR112019012158A2 (https=) |
| CA (1) | CA3047294A1 (https=) |
| MX (1) | MX2019006992A (https=) |
| PH (1) | PH12019501320A1 (https=) |
| RU (1) | RU2755345C2 (https=) |
| UA (1) | UA124976C2 (https=) |
| WO (1) | WO2018112169A2 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102012109B1 (ko) * | 2012-05-17 | 2019-08-19 | 조에티스 엘엘씨 | 이유 전 돼지 생식기 호흡기 증후군(prrs) 바이러스에 대한 효과적인 백신접종 |
| MX2019006992A (es) * | 2016-12-14 | 2019-08-29 | Zoetis Services Llc | Vacunacion eficaz contra cepas europeas del virus del sindrome reproductivo y respiratorio porcino (prrs) previo al destete. |
| CN119876049A (zh) | 2019-08-29 | 2025-04-25 | 礼蓝美国公司 | 猪繁殖与呼吸综合征疫苗病毒 |
| JP7369343B2 (ja) * | 2019-10-11 | 2023-10-26 | 国立研究開発法人農業・食品産業技術総合研究機構 | 豚感染ウイルスの製造方法 |
| CN111826468A (zh) * | 2020-08-07 | 2020-10-27 | 中国农业科学院兰州兽医研究所 | 一步法检测1型猪繁殖与呼吸综合征病毒的引物探针组和试剂盒 |
| EP4630048A1 (en) * | 2022-12-06 | 2025-10-15 | Zoetis Services LLC | Methods and compositions for vaccinating piglets against prrs-1 virus |
Family Cites Families (50)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3137631A (en) | 1959-12-01 | 1964-06-16 | Faberge Inc | Encapsulation in natural products |
| US3519710A (en) | 1967-08-10 | 1970-07-07 | Edmund P Bass | Direct active modified live virus vaccine immunization against transmissible gastroenteritis in swine piglets at birth |
| US3959457A (en) | 1970-06-05 | 1976-05-25 | Temple University | Microparticulate material and method of making such material |
| JPS5186117A (en) | 1975-01-27 | 1976-07-28 | Tanabe Seiyaku Co | Johoseibiryushiseizainoseiho |
| US4205060A (en) | 1978-12-20 | 1980-05-27 | Pennwalt Corporation | Microcapsules containing medicament-polymer salt having a water-insoluble polymer sheath, their production and their use |
| US4452747A (en) | 1982-03-22 | 1984-06-05 | Klaus Gersonde | Method of and arrangement for producing lipid vesicles |
| US4744933A (en) | 1984-02-15 | 1988-05-17 | Massachusetts Institute Of Technology | Process for encapsulation and encapsulated active material system |
| US5008050A (en) | 1984-06-20 | 1991-04-16 | The Liposome Company, Inc. | Extrusion technique for producing unilamellar vesicles |
| US4921706A (en) | 1984-11-20 | 1990-05-01 | Massachusetts Institute Of Technology | Unilamellar lipid vesicles and method for their formation |
| US4606940A (en) | 1984-12-21 | 1986-08-19 | The Ohio State University Research Foundation | Small particle formation and encapsulation |
| US5009956A (en) | 1987-02-24 | 1991-04-23 | Univ Minnesota | Phospholipase A2-resistant liposomes |
| US4927637A (en) | 1989-01-17 | 1990-05-22 | Liposome Technology, Inc. | Liposome extrusion method |
| US4944948A (en) | 1989-02-24 | 1990-07-31 | Liposome Technology, Inc. | EGF/Liposome gel composition and method |
| US5132117A (en) | 1990-01-11 | 1992-07-21 | Temple University | Aqueous core microcapsules and method for their preparation |
| JP3128133B2 (ja) | 1991-06-06 | 2001-01-29 | スティッチティング セントラール ディールゲネースクンディグ インスティトゥート | 豚の奇病の原因体であるレリスタドエイジェント、それを含むワクチン組成物、豚の奇病の診断キット及び診断方法 |
| KR0138092B1 (ko) | 1991-08-26 | 1998-04-30 | 제임스 씨. 데세사레 | 미확인(Mystery) 돼지 질병 관련 바이러스제 |
| DK0601062T4 (da) | 1991-08-26 | 2001-03-14 | Univ Minnesota | SIRS-vaccine og diagnosefremgangsmåde |
| US5846805A (en) | 1991-08-26 | 1998-12-08 | Boehringer Ingelheim Animal Health, Inc. | Culture of swine infertility and respiratory syndrome virus in simian cells |
| US6042830A (en) | 1992-08-05 | 2000-03-28 | Boehringer Ingelheim Vetmedica, Inc. | Viral agent associated with mystery swine disease |
| US6592873B1 (en) | 1992-10-30 | 2003-07-15 | Iowa State University Research Foundation, Inc. | Polynucleic acids isolated from a porcine reproductive and respiratory syndrome virus (PRRSV) and proteins encoded by the polynucleic acids |
| US6251397B1 (en) | 1992-10-30 | 2001-06-26 | Iowa State University Research Foundation, Inc. | Proteins encoded by polynucleic acids isolated from a porcine reproductive and respiratory syndrome virus and immunogenic compositions containing the same |
| US20040087521A1 (en) | 1993-03-18 | 2004-05-06 | Merck & Co., Inc. | Nucleic acid pharmaceuticals-influenza matrix |
| US6015686A (en) | 1993-09-15 | 2000-01-18 | Chiron Viagene, Inc. | Eukaryotic layered vector initiation systems |
| US5789543A (en) | 1993-12-30 | 1998-08-04 | President And Fellows Of Harvard College | Vertebrate embryonic pattern-inducing proteins and uses related thereto |
| JPH10500889A (ja) | 1994-04-15 | 1998-01-27 | テンプル・ユニバーシティ | 水性溶媒封入法、装置およびマイクロカプセル |
| PT702085E (pt) | 1994-07-18 | 2004-04-30 | Karl Klaus Conzelmann | Virus de arn de cadeia negativa nao segmentada infeccioso recombinante |
| WO1996004010A1 (en) | 1994-08-05 | 1996-02-15 | Regents Of The University Of Minnesota | Vr-2332 viral nucleotide sequence and methods of use |
| GB9518220D0 (en) | 1995-09-06 | 1995-11-08 | Medical Res Council | Checkpoint gene |
| US5866401A (en) | 1996-03-01 | 1999-02-02 | Schering Corporation | Porcine reproductive and respiratory syndrome vaccine |
| JPH09313188A (ja) | 1996-05-31 | 1997-12-09 | Kazuaki Chayama | Ｇ型肝炎ウイルス遺伝子 |
| EP0839912A1 (en) | 1996-10-30 | 1998-05-06 | Instituut Voor Dierhouderij En Diergezondheid (Id-Dlo) | Infectious clones of RNA viruses and vaccines and diagnostic assays derived thereof |
| WO1998055626A2 (en) | 1997-06-05 | 1998-12-10 | Origen, Inc. | Recombinant porcine reproductive and respiratory syndrome virus (prrsv) for use as a vaccine |
| AUPO856097A0 (en) | 1997-08-14 | 1997-09-04 | Commonwealth Scientific And Industrial Research Organisation | Vector |
| US5951977A (en) | 1997-10-14 | 1999-09-14 | The United States Of America, As Represented By The Secretary Of Agriculture | Competitive exclusion culture for swine |
| US7691389B2 (en) | 1998-12-22 | 2010-04-06 | Pfizer Inc | Infectious cDNA clone of north american porcine reproductive and respiratory syndrome (PRRS) virus and uses thereof |
| US7618797B2 (en) | 1998-12-22 | 2009-11-17 | Pfizer Inc | Infectious cDNA clone of North American porcine reproductive and respiratory syndrome (PRRS) virus and uses thereof |
| US7132106B2 (en) | 1998-12-22 | 2006-11-07 | Pfizer Inc. | Infectious cDNA clone of North American porcine reproductive and respiratory syndrome (PRRS) virus and uses thereof |
| CA2290220C (en) | 1998-12-22 | 2013-11-19 | Pfizer Products Inc. | An infectious cdna clone of north american porcine reproductive and respiratory syndrome (prrs) virus and uses thereof |
| US6943152B1 (en) | 1999-06-10 | 2005-09-13 | Merial | DNA vaccine-PCV |
| WO2005107796A2 (en) | 2004-04-23 | 2005-11-17 | Pharmacia & Upjohn Company, Llc | Cellular permissivity factor for viruses, and uses thereof |
| PL2369001T3 (pl) | 2005-06-24 | 2017-06-30 | Regents Of The University Of Minnesota | Wirusy PRRS, ich klony zakaźne, mutanty i sposoby stosowania |
| PL2106440T3 (pl) | 2007-01-12 | 2016-02-29 | Univ Illinois | Komórki niepochodzące od małp do hodowli wirusa zespołu rozrodczo-oddechowego świń (PRRS) |
| CA2694476C (en) | 2007-07-27 | 2017-06-27 | Universiteit Gent | Permissive cells and uses thereof |
| EP2328612A4 (en) * | 2008-08-25 | 2012-11-14 | Boehringer Ingelheim Vetmed | VACCINE AGAINST HIGH PATHOGENIC DISEASED LATE LIVESTOCK (PRRS) |
| UA108902C2 (uk) * | 2010-11-10 | 2015-06-25 | Вірус північноамериканського репродуктивного та респіраторного синдрому свиней (prrs) та його застосування | |
| HRP20151031T1 (hr) * | 2011-02-17 | 2015-11-06 | Boehringer Ingelheim Vetmedica Gmbh | Novi europski soj prrsv |
| UA114504C2 (uk) * | 2012-04-04 | 2017-06-26 | Зоетіс Сервісіз Ллс | Комбінована вакцина pcv, mycoplasma hyopneumoniae та prrs |
| KR102012109B1 (ko) * | 2012-05-17 | 2019-08-19 | 조에티스 엘엘씨 | 이유 전 돼지 생식기 호흡기 증후군(prrs) 바이러스에 대한 효과적인 백신접종 |
| HUE054877T2 (hu) * | 2014-07-21 | 2021-10-28 | Fatro Spa | PRRS legyengített törzse és lehetséges alkalmazása immunizáló készítményekben |
| MX2019006992A (es) * | 2016-12-14 | 2019-08-29 | Zoetis Services Llc | Vacunacion eficaz contra cepas europeas del virus del sindrome reproductivo y respiratorio porcino (prrs) previo al destete. |
-
2017
- 2017-12-14 MX MX2019006992A patent/MX2019006992A/es unknown
- 2017-12-14 AU AU2017378336A patent/AU2017378336B2/en active Active
- 2017-12-14 EP EP17829078.9A patent/EP3554537A2/en active Pending
- 2017-12-14 BR BR112019012158-7A patent/BR112019012158A2/pt unknown
- 2017-12-14 RU RU2019117647A patent/RU2755345C2/ru active
- 2017-12-14 UA UAA201906661A patent/UA124976C2/uk unknown
- 2017-12-14 KR KR1020197017275A patent/KR20190085977A/ko not_active Ceased
- 2017-12-14 CA CA3047294A patent/CA3047294A1/en active Pending
- 2017-12-14 CN CN201780077455.5A patent/CN110072547B/zh active Active
- 2017-12-14 JP JP2019532094A patent/JP7129978B2/ja active Active
- 2017-12-14 US US16/469,321 patent/US11090376B2/en active Active
- 2017-12-14 KR KR1020217030759A patent/KR102602018B1/ko active Active
- 2017-12-14 WO PCT/US2017/066347 patent/WO2018112169A2/en not_active Ceased
-
2019
- 2019-06-11 PH PH12019501320A patent/PH12019501320A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP3554537A2 (en) | 2019-10-23 |
| CN110072547A (zh) | 2019-07-30 |
| KR20190085977A (ko) | 2019-07-19 |
| RU2755345C2 (ru) | 2021-09-15 |
| CN110072547B (zh) | 2024-04-30 |
| US20190365881A1 (en) | 2019-12-05 |
| AU2017378336A1 (en) | 2019-05-30 |
| RU2019117647A (ru) | 2021-01-15 |
| BR112019012158A2 (pt) | 2019-11-12 |
| KR102602018B1 (ko) | 2023-11-15 |
| CA3047294A1 (en) | 2018-06-21 |
| JP2020502158A (ja) | 2020-01-23 |
| AU2017378336B2 (en) | 2024-06-06 |
| JP7129978B2 (ja) | 2022-09-02 |
| KR20210121293A (ko) | 2021-10-07 |
| UA124976C2 (uk) | 2021-12-22 |
| WO2018112169A2 (en) | 2018-06-21 |
| WO2018112169A3 (en) | 2018-07-26 |
| RU2019117647A3 (https=) | 2021-01-20 |
| PH12019501320A1 (en) | 2020-03-02 |
| US11090376B2 (en) | 2021-08-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12019501320A1 (en) | Effective vaccination against european strains of porcine reproductive and respiratory syndrome (prrs) virus prior to weaning | |
| AR134554A2 (es) | Composición inmunológica o de vacuna y método para producir una respuesta protectora contra prrsv en un animal | |
| SA515360198B1 (ar) | لقاحات غمس الوحدات الفرعية للسمك | |
| LT3331355T (lt) | Kiaulių reprodukcinio ir respiracinio sindromo virusui (prrsv) atsparios kiaulės ir ląstelės, turinčios modifikuotus cd163 genus | |
| MY199422A (en) | Methods of manufacturing an immunogenic composition comprising a recombinant protein | |
| ZA202204373B (en) | Development of a novel live attenuated african swine fever vaccine based in the deletion of gene i177l | |
| MX388128B (es) | Vacuna combinada para cerdos. | |
| WO2014150822A3 (en) | Porcine reproductive and respiratory syndrome virus, compositions, vaccine and methods of use | |
| BR112018012642A2 (pt) | vacina de calicivírus felino | |
| MX2018006416A (es) | Metodos para el tratamiento, prevencion y diagnostico de infeccion por el virus de la diarrea epidemica porcina. | |
| BR112017002496A2 (pt) | agente de controle contra a síndrome reprodutiva e respiratória porcina | |
| PH12018502436A1 (en) | Multivalent vaccines major swine viral diseases | |
| PH12018501750A1 (en) | Porcine reproductive and respiratory syndrome vaccine virus | |
| PH12020550204A1 (en) | A non-naturally occurring porcine reproductive and respiratory syndrome virus (prrsv) and methods of using | |
| PH12017500419A1 (en) | Recoded arbovirus and vaccines | |
| MX366263B (es) | Parvovirus porcino 5b, metodos de uso y vacuna. | |
| NZ743977A (en) | M hyo multivalent vaccine and uses thereof | |
| MX2019007924A (es) | Vacunas contra la influenza. | |
| CA3045626A1 (en) | Bovine herpesvirus type 1 (bohv-1) vector against bovine respiratory disease complex | |
| PH12021552641A1 (en) | Recombinant classical swine fever virus | |
| WO2016012406A3 (en) | Attenuated strain of prrs and potential use in immunising preparations | |
| PH12019550018A1 (en) | Porcine reproductive and respiratory syndrome virus cdna clone and uses thereof | |
| BR112015020604A2 (pt) | vírus da leucemia bovina (blv) atenuado recombinante, ácido nucleico, vetor, plasmídeo, célula hospedeira, composição farmacêutica, vacina, animal não humano, método de obtenção de material de animal não humano e material derivado de animal não humano | |
| Perez-Giron et al. | P114 Modulation of vaccine-induced T cell immunity by specific adjuvants | |
| UA88693U (uk) | Штам вірусу інфекційного панкреатичного некрозу ізолят "карпати" (ipnv "karpaty") для отримання вакцини проти інфекційного некрозу підшлункової залози лососевих |